BRPI0405842A - stabilized pharmaceutical composition of fluorine ether compound for anesthetic use. method for stabilizing a fluorine ether compound. use of stabilizing agent to prevent the degradation of fluorine ether compound - Google Patents
stabilized pharmaceutical composition of fluorine ether compound for anesthetic use. method for stabilizing a fluorine ether compound. use of stabilizing agent to prevent the degradation of fluorine ether compoundInfo
- Publication number
- BRPI0405842A BRPI0405842A BRPI0405842A BRPI0405842A BR PI0405842 A BRPI0405842 A BR PI0405842A BR PI0405842 A BRPI0405842 A BR PI0405842A BR PI0405842 A BRPI0405842 A BR PI0405842A
- Authority
- BR
- Brazil
- Prior art keywords
- ether compound
- fluorine ether
- stabilizing
- degradation
- pharmaceutical composition
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA ESTABILIZADA DE COMPOSTO FLúOR-éTER PARA USO ANESTéSICO. MéTODO PAPA ESTABILIZAR UM COMPOSTO FLúOR-éTER. USO DE AGENTE ESTABILIZANTE PARA IMPEDIR A DEGRADAçãO DE COMPOSTO FLúOR éTER". A presente invenção tem como objetivo a estabilização de um composto flúor-éter contra a degradação proporcionada por substâncias ácidas. Os estabilizantes empregados são selecionados dentre compostos farmacêuticos apropriados e são utilizados no preparo de composições farmacêuticas estabilizadas de um composto flúor-éter. São também descritos método de estabilização de um composto flúor-éter e uso de agentes estabilizantes para impedir a degradação de um composto flúor-éter."STABILIZED PHARMACEUTICAL COMPOSITION OF FLUOR-ETHER COMPOUND FOR ANESTHETIC USE. METHOD FOR STABILIZING A FLUOR-ETHER COMPOSITE. The present invention aims at stabilizing a fluorine ether compound against the degradation provided by acidic substances. The stabilizers employed are selected from the appropriate pharmaceutical compounds and are used in the preparation of stabilized pharmaceutical compositions of a fluorine ether compound. Also described are methods of stabilizing a fluorine ether compound and use of stabilizing agents to prevent degradation of a fluorine ether compound.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0405842A BRPI0405842B8 (en) | 2004-07-29 | 2004-07-29 | stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound. |
PT04737744T PT1663186E (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
ES04737744T ES2289524T3 (en) | 2003-09-10 | 2004-08-20 | STABLE PHARMACEUTICAL COMPOSITION OF A FLUOROETER COMPOSITE FOR ANESTHETIC USE, PROCEDURE FOR STABILIZING A FLUOROETER COMPOUND, USE OF A STABILIZING AGENT TO AVOID THE DEGRADATION OF A FLUOROETER COMPOUND. |
PCT/BR2004/000156 WO2005023175A2 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
DE602004007149T DE602004007149T2 (en) | 2003-09-10 | 2004-08-20 | A STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZER TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND |
AT04737744T ATE365034T1 (en) | 2003-09-10 | 2004-08-20 | STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZING AGENT TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND |
US10/566,466 US7816409B2 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
JP2006525578A JP4253343B2 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of anesthesia fluoroether compound, method for stabilizing fluoroether compound, use of stabilizer to prevent degradation of fluoroether compound |
MXPA06000803A MXPA06000803A (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound. |
CN2004800211331A CN1997360B (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether com |
EP04737744A EP1663186B1 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
PL04737744T PL1663186T3 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
HK07113847.1A HK1108633A1 (en) | 2003-09-10 | 2007-12-19 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0405842A BRPI0405842B8 (en) | 2004-07-29 | 2004-07-29 | stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound. |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0405842A true BRPI0405842A (en) | 2006-03-14 |
BRPI0405842B1 BRPI0405842B1 (en) | 2014-11-11 |
BRPI0405842B8 BRPI0405842B8 (en) | 2021-05-25 |
Family
ID=36091897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0405842A BRPI0405842B8 (en) | 2003-09-10 | 2004-07-29 | stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound. |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0405842B8 (en) |
-
2004
- 2004-07-29 BR BRPI0405842A patent/BRPI0405842B8/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BRPI0405842B8 (en) | 2021-05-25 |
BRPI0405842B1 (en) | 2014-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0508579A (en) | compound, pharmaceutical composition, and use of a compound | |
BR112022024943A2 (en) | EFERVESCENT ORAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT | |
BRPI0415121A (en) | particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form | |
BRPI0615292A8 (en) | compositions and methods for preparing poorly soluble water drugs with increased stability | |
TW200733968A (en) | Stabilized lanthanum carbonate compositions | |
BRPI0606318A2 (en) | compound, composition, and use of a compound | |
MX2009004475A (en) | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same. | |
PE20100265A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION | |
WO2007145991A3 (en) | Anti-inflammatory and analgesic compositions and related methods | |
GEP20125628B (en) | Pharmaceutical compositions containing antagonist anti-cd40 antibody | |
RS51304B (en) | Pharmaceutical compositions of a neuroactive steroid and uses thereof | |
ECSP088653A (en) | PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE PRINCIPLES AND AT LEAST A TENSOACTIVE SUBSTANCE | |
BRPI0418270A (en) | methods of treatment and control, treatment or prevention, control of a central nervous system disorder, and to reduce or prevent an adverse effect, and, pharmaceutical composition | |
BRPI0509708A (en) | pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and / or medium chain triglycerides | |
WO2006113631A3 (en) | Bioenhanced compositions | |
BRPI0518781A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, and use of a compound | |
BRPI0511466B8 (en) | peptide vasopressin receptor agonists, pharmaceutical composition comprising said agonists and use thereof | |
MX2010003923A (en) | Pharmaceutical formulation of valsartan. | |
CY1111369T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING 3- (3-DIMETHYLAMINE-1-ETHYL-2-Methyl-PROPYL) -PHENOL AND PARAKETAMOL | |
HK1108633A1 (en) | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound | |
BRPI0514250A (en) | use of a compound, pharmaceutical composition comprising the same, compounds and method of treatment | |
BRPI0916282B8 (en) | use of a pgi2-receptor agonist in the treatment of chronic renal failure | |
DK1635792T3 (en) | Stable pharmaceutical compositions of 2-aza-bicyclo-3.3.0-octane-3-carboxylic acid derivatives | |
MX2010006259A (en) | Piperazines as anti-obesity agents. | |
BRPI0409413A (en) | pharmaceutical composition, use of an unconjugated bile acid or salt, and methods for enhancing the absorption of an active macromolecular principle in a pacetella and for treating a patient suffering from a treatable condition or disease. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 31/08, 47/10; C07C 17/42, 19/08; A61P 23/00 Ipc: A61K 31/08 (2011.01), A61K 47/10 (2011.01), C07C 1 |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/11/2014, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/07/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |